Correlation of preoperative myocardial function, perfusion, and metabolism with postoperative function at rest and stress after bypass surgery in severe left ventricular dysfunction

American Journal of Cardiology

Volumn 84, Issue 1, 1999, Pages 58-64

  Pasquet, Agnes ^a,b   Williams, M John ^a,b   Secknus, Maria Anna ^a,b   Zuchowski, Charis ^a,b   Lytle, Bruce W ^a,b   Marwick, Thomas H ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DIPYRIDAMOLE; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DIAGNOSTIC ACCURACY; DISEASE COURSE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME;

CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; DOBUTAMINE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033060501     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00192-7     Document Type: Article

References (30)

1. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary artery bypass surgery for chronic stable angina. Circulation 1985;81(suppl V):V-123-V-135.
2. Tillisch J., Brunken R., Marshall R., Schwaiger M., Mandelkern M., Phelps M., Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 314:1986;884-888.
3. Di Carli M.F., Davidson M., Little R., Khanna S., Mody F.V., Brunken R.C., Rokhsar S., Stevenson L.W., Laks H., Louie H.W. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 73:1994;527-533.
4. Lee K.S., Marwick T.H., Cook S.A., Go R.T., Fix J.S., James K.B., Sapp S.K., Thomas J.D. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation. 90:1994;2687-2694.
5. Pierard L.A., De Landsheere C.M., Berthe C., Rigo P., Kulbertus H.E. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy comparison with positron emission tomography . J Am Coll Cardiol. 15:1990;1021-1031.
6. Smart S.C., Sawada S., Ryan T., Segar D., Atherton L., Berkovitz K., Feigenbaum H. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation. 88:1993;405-415.
7. La Canna G., Alfieri O., Giubbini R., Gargano M., Ferrari R., Visioli O. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 23:1994;617-626.
8. Cigarroa C.G., deFilippi C.R., Brickner M.E., Alvarez L.G., Wait M.A., Grayburn P.A. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation. 88:1993;430-436.
9. Arnese M., Cornel J.H., Salustri A., Maat A., Elhendy A., Reijs A.E., tenCate F.J., Keane D., Balk A.H., Roelandt J.R., et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation. 91:1995;2748-2752.
10. Vanoverschelde J.L., Marwick T.H., Gerber B.L., De Kock M., Dion R., Wijns W., Melin J.A. Head to head comparison between of exercise redistribution reinjection thallium single photon emission tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left left ventricular ischemic dysfunction. J Am Coll Cardiol. 28:1996;432-442.
11. Qureshi U., Nagueh S.F., Afridi I., Vaduganathan P., Blaustein A., Verani M.S., Winters W.L. Jr, Zoghbi W.A. Dobutamine echocardiography and quantitative rest redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function. Circulation. 85:1997;626-635.
12. Bax J.J., Wijns W., Cornel J.H., Visser F.C., Boersma E., Fioretti P.M. Accuracy of currently available techniques for prediction of functional recivery after revascularisation in patients with left ventricular dysfunction due to chronic coronary artery disease:comparison of pooled data. J Am Coll Cardiol. 30:1997;1451-1460.
13. Bonow R.O. Identification of viable myocardium. Circulation. 94:1996;2674-2680.
14. Pagano D., Bonser R.S., Townend J.N., Ourdoubadi F., Lorenzoni R., Camici P.G. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart. 79:1998;281-288.
15. Kaul S. There may be more to myocardial viability than meets the eye. Circulation. 92:1995;2790-2793.
16. Go R.T., Marwick T.H., MacIntyre W.J., Saha G.B., Neumann D.R., Underwood D.A. A prospective comparison of rubidium82 PET and thallium201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med. 31:1990;1899-1905.
17. Schelbert HR. Positron emission tomography for the assessment of myocardial viability. Circulation 1991;84(suppl I):I-122-I-131.
18. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reicheck N., Sahn D., Schnittger I., et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two Dimensional Echocardiograms. J Am Soc Echo. 2:1989;258-367.
19. Williams M.J., Odabashian J., Lauer M.S., Thomas J.D., Marwick T.H. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 27:1996;132-139.
20. Baer F.M., Voth E., Deutsch H.J., Schneider C.A., Horst M., deVivie E.R., Schicha H., Erdmann E., Sechtem U. Predictive value of low dose dobutamine transesophageal echocardiography and 18-FDG postiron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol. 28:1996;60-69.
21. Chan R.K.M., Lee K.J., Calafiore P., Berlangieri S.U., McKay W.J., Tonkin A.M. Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol. 27:1996;1601-1607.
22. Tamaki N., Kawamoto M., Tadamura E., Magata Y., Yonekura Y., Nohara R., Nishimura K., Ban T., Konishi J. Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation. 91:1995;1697-1705.
23. Gropler R.J., Geltman E.M., Sampathkumaran K., Perez J.E., Schechtman K.B., Sobel B.E., Bergmann S.R., Siegel B.A. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol. 22:1993;1587-1597.
24. Knuuti M.J., Saraste M., Nuutila P., Harkonen R., Wegelius U., Haapanen A., Haaparanta M., Savunen T., Voipio-Pulkki L.M. Myocardial viability fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization . Am Heart J. 127:1994;785-796.
25. vom Dahl J., Eitzman D.T., al-Aouar Z.R., Kanter H.L., Hicks R.J., Deeb G.M., Schwaiger M. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation. 90:1994;2356-2366.
26. Maes A., Flameng W., Nuyts J., Borgers M., Shivalkar B., Ausma J., Bormans G., Schiepers C., De Roo M., Mortelmans L. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation. 90:1994;735-745.
27. Lamas G.A., Flaker G.C., Mitchell G., Smith S.C. Jr, Gersch B.J., Wun C.C., Moye L., Rouleau J.L., Rutherford J.D., Pfeffer M.A., et al. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. Circulation. 92:1995;1101-1109.
28. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? Circulation. 79:1989;441-444.
29. Myers J.H., Stirling M.C., Choy M., Buda A.J., Gallagher K.P. Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography. Circulation. 74:1986;164-172.
30. Sklenar J., Villanueva F.S., Glasheen W.P., Ismail S., Goodman S.C., Kaul S. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion, an experimental evaluation. Circulation. 90:1994;1503-1512.